Switch theme
Sign up to access all valuation multiples
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.
1990
2.9K+
LTM Revenue $1.0B
LTM EBITDA $260M
$713M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cresco Labs has a last 12-month revenue (LTM) of $1.0B and a last 12-month EBITDA of $260M.
In the most recent fiscal year, Cresco Labs achieved revenue of $523M and an EBITDA of $82.5M.
Cresco Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cresco Labs valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.0B | XXX | $523M | XXX | XXX | XXX |
| Gross Profit | $501M | XXX | $263M | XXX | XXX | XXX |
| Gross Margin | 50% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $260M | XXX | $82.5M | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 16% | XXX | XXX | XXX |
| EBIT | $134M | XXX | $79.5M | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | -$68.9M | XXX | -$53.7M | XXX | XXX | XXX |
| Net Margin | -7% | XXX | -10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $240M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cresco Labs's stock price is CAD 1 (or $1).
Cresco Labs has current market cap of CAD 293M (or $211M), and EV of CAD 988M (or $713M).
See Cresco Labs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $713M | $211M | XXX | XXX | XXX | XXX | $-0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cresco Labs has market cap of $211M and EV of $713M.
Cresco Labs's trades at 1.4x EV/Revenue multiple, and 8.6x EV/EBITDA.
Equity research analysts estimate Cresco Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cresco Labs has a P/E ratio of -4.3x.
See valuation multiples for Cresco Labs and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $211M | XXX | $211M | XXX | XXX | XXX |
| EV (current) | $713M | XXX | $713M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 3.8x | XXX | 8.6x | XXX | XXX | XXX |
| EV/EBIT | 7.4x | XXX | 9.0x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -4.3x | XXX | -3.9x | XXX | XXX | XXX |
| EV/FCF | 8.8x | XXX | 9.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCresco Labs's last 12 month revenue growth is -4%
Cresco Labs's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Cresco Labs's rule of 40 is -6% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cresco Labs's rule of X is 16% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cresco Labs and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -4% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | -11% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -6% | XXX | 12% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Grown Rogue | XXX | XXX | XXX | XXX | XXX | XXX |
| Green Thumb Indus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cresco Labs acquired XXX companies to date.
Last acquisition by Cresco Labs was XXXXXXXX, XXXXX XXXXX XXXXXX . Cresco Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cresco Labs founded? | Cresco Labs was founded in 1990. |
| Where is Cresco Labs headquartered? | Cresco Labs is headquartered in Canada. |
| How many employees does Cresco Labs have? | As of today, Cresco Labs has 2.9K+ employees. |
| Is Cresco Labs publicy listed? | Yes, Cresco Labs is a public company listed on CNQ. |
| What is the stock symbol of Cresco Labs? | Cresco Labs trades under CL ticker. |
| When did Cresco Labs go public? | Cresco Labs went public in 1991. |
| Who are competitors of Cresco Labs? | Similar companies to Cresco Labs include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Grown Rogue. |
| What is the current market cap of Cresco Labs? | Cresco Labs's current market cap is $211M |
| What is the current revenue of Cresco Labs? | Cresco Labs's last 12 months revenue is $1.0B. |
| What is the current revenue growth of Cresco Labs? | Cresco Labs revenue growth (NTM/LTM) is -4%. |
| What is the current EV/Revenue multiple of Cresco Labs? | Current revenue multiple of Cresco Labs is 1.0x. |
| Is Cresco Labs profitable? | Yes, Cresco Labs is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cresco Labs? | Cresco Labs's last 12 months EBITDA is $260M. |
| What is Cresco Labs's EBITDA margin? | Cresco Labs's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Cresco Labs? | Current EBITDA multiple of Cresco Labs is 3.8x. |
| What is the current FCF of Cresco Labs? | Cresco Labs's last 12 months FCF is $112M. |
| What is Cresco Labs's FCF margin? | Cresco Labs's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Cresco Labs? | Current FCF multiple of Cresco Labs is 8.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
